Drugs of the future consign to the past

The suspension global pharmaceutical companies clinical trials of the drugs to Russian Federation will significantly complicate access of patients to preparations of new generation. In the next ten years about 300 developed drugs can not enter the market, including for fight against incurable diseases considered now. The Russian development in these directions while is single. Drawing: Chumachev Victor, newspaper "Kommersant" In the next ten years the Russian patients can not receive about 300 preparations developed now by the international pharmaceutical companies. About it it is spoken in Center research on...